C12Y 302/01036
Hyaluronoglucuronidase
Official title: Hyaluronoglucuronidase (3.2.1.36)
C12Y302/01036 (Hyaluronoglucuronidase) appears on 16 US grants and 26 published applications in this corpus.
Search patents in C12Y- Granted patents
- 16
- Published applications
- 26
- Assignees
- 13
- Inventors
- 47
- Latest grant
- 24 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 2 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 1 | 2 |
| 2012 | 1 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 2 |
| 2016 | 2 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 3 |
| 2022 | 0 | 1 |
| 2023 | 2 | 3 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions for use to treat advanced glycation end products-dependent ocular diseases24 Dec 2024US 12,171,811 B2Universiteit Gent
- Strain of Enterobacter for degrading hyaluronic acid and application thereof7 Nov 2023US 11,807,847 B2Jiangnan University
- Methods and devices related to controlled delivery of phages as a theranostic tool6 Jun 2023US 11,667,895 B2The Board of Trustees of The University of Alabama
- Proteoglycan degrading mutants for treatment of CNS27 Dec 2016US 9,528,102 B2Acorda Therapeutics, Inc.
- Leech hyaluronidase and its application8 Mar 2016US 9,279,111 B2Jiangnan University
- Co-administration of a hyaluronidase and anti-c5 antibody for treatment of complement-associated conditions25 Jun 2026US 2026/0176340 A1Alexion Pharmaceuticals, Inc.
- Peri-orbital fullness assessment scale and methods of use thereof11 Jan 2024US 2024/0009282 A1
- Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone19 Oct 2023US 2023/0330224 A1Janssen Biotech, Inc.
- Strain of enterobacter for degrading hyaluronic acid and application thereof26 Jan 2023US 2023/0024365 A1Jiangnan University
- Hyaluronidase compositions and methods of using same to treat peri-orbital hollowness and tear through deformities19 Jan 2023US 2023/0012731 A1Standard of Care Corporation
Most cited
By later US patents
- Use of human plasma hyaluronidase in cancer treatment72US 7,148,201 B2The Regents of the University of California · 2006
- Method of treating tumor-bearing patients with human plasma hyaluronidase70US 6,193,963 B1The Regents of the University of California · 2001
- Human plasma hyaluronidase67US 7,105,330 B2The Regents of the University of California · 2006
- Large-scale production of soluble hyaluronidase58US 8,187,855 B2Halozyme, Inc. · 2012
- Human plasma hyaluronidase54US 7,781,397 B2The Regents of the University of California · 2010